Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma

Prescription Drug User Fee Act (PDUFA) target action date set for September 28, 2026If approved, Ameluz® would be the first and only PDT ...
EurekAlert!

Research spotlight: Basal cell carcinoma’s low immunogenicity is associated with suppression of antigen presentation stemming from its cell of origin

Basal cell carcinoma has low immunogenicity. Tumor cells express Foxc1 protein (red), which suppresses HLA class I (green) in the tumor cells. Compromised antigen presentation ranks among the top ...
Nature

Basal Cell Carcinoma Research

Basal cell carcinoma (BCC) represents the most prevalent form of skin cancer, with research efforts increasingly focused on elucidating its molecular underpinnings and improving therapeutic strategies ...
Hosted on MSN

Pictures of What Skin Cancer Looks Like

Skin cancer is a type of cancer that begins in the skin cells, and its appearance can vary widely depending on the type of cancer. Understanding the variations in what skin cancer looks like can help ...